ProQR Therapeutics (PRQR) Receivables Refunds (2020 - 2025)
ProQR Therapeutics' Receivables Refunds history spans 6 years, with the latest figure at $1.1 million for Q4 2025.
- On a quarterly basis, Receivables Refunds rose 44.14% to $1.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.1 million, a 44.14% increase, with the full-year FY2025 number at $1.1 million, up 44.14% from a year prior.
- Receivables Refunds hit $1.1 million in Q4 2025 for ProQR Therapeutics, up from $737330.8 in the prior quarter.
- Over the last five years, Receivables Refunds for PRQR hit a ceiling of $1.1 million in Q4 2025 and a floor of $435569.8 in Q2 2023.
- Historically, Receivables Refunds has averaged $657478.5 across 5 years, with a median of $598121.6 in 2023.
- Biggest five-year swings in Receivables Refunds: crashed 46.18% in 2023 and later surged 44.14% in 2025.
- Tracing PRQR's Receivables Refunds over 5 years: stood at $634903.9 in 2021, then fell by 2.46% to $619290.2 in 2022, then fell by 6.84% to $576953.0 in 2023, then increased by 27.8% to $737330.8 in 2024, then skyrocketed by 44.14% to $1.1 million in 2025.
- Business Quant data shows Receivables Refunds for PRQR at $1.1 million in Q4 2025, $737330.8 in Q4 2024, and $576953.0 in Q3 2023.